REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,310,448 | -62.6% | 114,250 | -17.6% | 0.00% | -76.9% |
| Q2 2023 | $3,507,890 | +105.4% | 138,597 | +161.4% | 0.01% | +85.7% |
| Q1 2023 | $1,707,806 | -34.8% | 53,021 | -62.6% | 0.01% | -50.0% |
| Q4 2022 | $2,619,105 | +238.4% | 141,880 | +394.9% | 0.01% | +180.0% |
| Q3 2022 | $774,000 | +11.4% | 28,669 | +22.3% | 0.01% | -37.5% |
| Q2 2021 | $695,000 | +92.5% | 23,435 | +63.3% | 0.01% | +60.0% |
| Q3 2020 | $361,000 | +12.8% | 14,353 | +9.4% | 0.01% | 0.0% |
| Q2 2020 | $320,000 | – | 13,117 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
| Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
| Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
| Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
| FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
| Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
| Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |